Overexpression of the vesicular acetylcholine transporter increased acetylcholine release in the hippocampus

Neuroscience

Volumn 218, Issue , 2012, Pages 1-11

  Nagy, P M ^a,b   Aubert, I ^a,b  

^a Canada   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

ChAT; Choline acetyltransferase; Cholinergic; EGFP ChAT; Septum; VAChT

Indexed keywords

MESSENGER RNA; VESICULAR ACETYLCHOLINE TRANSPORTER;

ACETYLCHOLINE RELEASE; ANIMAL TISSUE; ARTICLE; CHOLINERGIC NERVE CELL; CHOLINERGIC TRANSMISSION; CONTROLLED STUDY; EX VIVO STUDY; FEMALE; GENE DOSAGE; GENE EXPRESSION; HIPPOCAMPAL SLICE; HIPPOCAMPUS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CONTENT; PROTEIN EXPRESSION; SEPTUM PELLUCIDUM; TISSUE SLICE; TRANSGENIC MOUSE;

ACETYLCHOLINE; ANIMALS; BLOTTING, WESTERN; FEMALE; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, TRANSGENIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SYNAPTIC TRANSMISSION; VESICULAR ACETYLCHOLINE TRANSPORT PROTEINS;

EID: 84863780825     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2012.05.047     Document Type: Article

References (48)

1. Barbosa J., Clarizia A.D., Gomez M.V., Romano-Silva M.A., Prado V.F., Prado M.A.M. Effect of protein kinase C activation on the release of [3H] acetylcholine in the presence of vesamicol. J Neurochem 1997, 69:2608-2611.
2. Bell K.F.S., Cuello A.C. Altered synaptic function in Alzheimer's disease. Eur J Pharmacol 2006, 545:11-21.
3. Berse B., Blusztajn J.K. Coordinated up-regulation of choline acetyltransferase and vesicular acetylcholine transporter gene expression by the retinoic acid receptor α, cAMP, and leukemia inhibitory factor/ciliary neurotrophic factor signaling pathways in a murine septal cell line. J Biol Chem 1995, 270:22101-22104.
4. Blusztajn J.K., Wurtman R.J. Choline and cholinergic neurons. Science 1983, 221:614-620.
5. Brandon E.P., Mellott T., Pizzo D.P., Coufal N., D'Amour K.A., Gobeske K., Lortie M., Lopez-Coviella I., Berse B., Thal L.J., Gage F.H., Blusztajn J.K. Choline transporter 1 maintains cholinergic function in choline acetyltransferase haploinsufficiency. J Neurosci 2004, 24:5459-5466.
6. Breer H., Knipper M. Regulation of high affinity choline uptake. J Neurobiol 1990, 21:269-275.
7. Chandler K.J., Chandler R.L., Broeckelmann E.M., Hou Y., Southard-Smith E.M., Mortlock D.P. Relevance of BAC transgene copy number in mice. Transgene copy number variation across multiple transgenic lines and correlations with transgene integrity and expression. Mamm Genome 2007, 18:693-708.
8. Chen K.H., Reese E.A., Kim H.W., Rapoport S.I., Rao J.S. Disturbed neurotransmitter transporter expression in Alzheimer's disease brain. J Alzheimers Dis 2011, 26:755-766.
9. Cooper J.R. A simple method to determine released acetylcholine in the presence of choline. Life Sci 1989, 45:2041-2042.
10. Cui X., Weng Y.Q., Frappé I., Burgess A., Girão da Cruz M.T., Schachner M., Aubert I. The cell adhesion molecule L1 regulates the expression of choline acetyltransferase and the development of septal cholinergic neurons. Brain Behav 2011, 1:73-86.
11. de Castro B.M., Pereira G.S., Magalhães V., Rossato J.I., De Jaeger X., Martins-Silva C., Leles B., Lima P., Gomez M.V., Gainetdinov R.R., Caron M.G., Izquierdo I., Cammarota M., Prado V.F., Prado M.A.M. Reduced expression of the vesicular acetylcholine transporter causes learning deficits in mice. Genes Brain Behav 2009, 8:23-35.
12. Drever B.D., Riedel G., Platt B. The cholinergic system and hippocampal plasticity. Behav Brain Res 2011, 221:505-514.
13. Efange S.M.N., Garland E.M., Staley J.K., Khare A.B., Mash D.C. Vesicular acetylcholine transporter density and Alzheimer's disease. Neurobiol Aging 1997, 18:407-413.
14. Eiden L.E. The cholinergic gene locus. J Neurochem 1998, 70:2227-2240.
15. Ferguson S.M., Bazalakova M., Savchenko V., Tapia J.C., Wright J., Blakely R.D. Lethal impairment of cholinergic neurotransmission in hemicholinium-3-sensitive choline transporter knockout mice. Proc Natl Acad Sci 2004, 101:8762-8767.
16. Fonnum F. Radiochemical micro assays for the determination of choline acetyltransferase and acetylcholinesterase activities. Biochem J 1969, 115:465-472.
17. Gilmor M.L., Nash N.R., Roghani A., Edwards R.H., Yi H., Hersch S.M., Levey A.I. Expression of the putative vesicular acetylcholine transporter in rat brain and localization in cholinergic synaptic vesicles. J Neurosci 1996, 16:2179-2190.
18. Giraldo P., Montoliu L. Size matters: Use of YACs, BACs and PACs in transgenic animals. Transgenic Res 2001, 10:83-103.
19. Guzman M.S., De Jaeger X., Raulic S., Souza I.A., Li A.X., Schmid S., Menon R.S., Gainetdinov R.R., Caron M.G., Bartha R., Prado V.F., Prado M.A.M. Elimination of the vesicular acetylcholine transporter in the striatum reveals regulation of behaviour by cholinergic-glutamatergic co-transmission. PLoS Biology 2011, 9:e1001194.
20. Hartmann J., Kiewert C., Duysen E.G., Lockridge O., Klein J. Choline availability and acetylcholine synthesis in the hippocampus of acetylcholinesterase-deficient mice. Neurochem Int 2008, 52:972-978.
21. Heaney J.D., Bronson S.K. Artificial chromosome-based transgenes in the study of genome function. Mamm Genome 2006, 17:791-807.
22. Hersh L.B. Kinetic studies of the choline acetyltransferase reaction using isotope exchange at equilibrium. J Biol Chem 1982, 257:12820-12825.
23. Holler T., Berse B., Cermak J.M., Diebler M.F., Blusztajn J.K. Differences in the developmental expression of the vesicular acetylcholine transporter and choline acetyltransferase in the rat brain. Neurosci Lett 1996, 212:107-110.
24. Jaenisch R. Transgenic animals. Science 1988, 240:1468-1474.
25. Kim S.J., Martinson H.G. Poly(A)-dependent transcription termination: continued communication of the poly(A) signal with the polymerase is required long after extrusion in vivo. J Biol Chem 2003, 278:41691-41701.
26. Lanari A., Amenta F., Silvestrelli G., Tomassoni D., Parnetti L. Neurotransmitter deficits in behavioural and psychological symptoms of Alzheimer's disease. Mech Ageing Dev 2006, 127:158-165.
27. Lanctôt K.L., Herrmann N., Yau K.K., Khan L.R., Liu B.A., LouLou M.M., Einarson T.R. Efficacy and safety of cholinesterase inhibitors in Alzheimer's disease: a meta-analysis. Can Med Assoc J 2003, 169:557-564.
28. Lopez-Coviella I., Mellott T.J., Schnitzler A.C., Blusztajn J.K. BMP9 protects septal neurons from axotomy-evoked loss of cholinergic phenotype. PLoS One 2011, 6:e21166.
29. Martins-Silva C., De Jaeger X., Guzman M.S., Lima R.D.F., Santos M.S., Kushmerick C., Gomez M.V., Caron M.G., Prado M.A.M., Prado V.F. Novel strains of mice deficient for the vesicular acetylcholine transporter: insights on transcriptional regulation and control of locomotor behavior. PLoS One 2011, 6:e17611.
30. Matsuo A., Bellier J.P., Nishimura M., Yasuhara O., Saito N., Kimura H. Nuclear choline acetyltransferase activates transcription of a high-affinity choline transporter. J Biol Chem 2011, 286:5836-5845.
31. Misawa H., Matsuura J., Oda Y., Takahashi R., Deguchi T. Human choline acetyltransferase mRNAs with different 5'-region produce a 69-kDa major translation product. Mol Brain Res 1997, 44:323-333.
32. Oda Y. Choline acetyltransferase: the structure, distribution and pathologic changes in the central nervous system. Pathol Int 1999, 49:921-937.
33. Ohno K., Tsujino A., Brengman J.M., Harper C.M., Bajzer Z., Udd B., Beyring R., Robb S., Kirkham F.J., Engel A.G. Choline acetyltransferase mutations cause myasthenic syndrome associated with episodic apnea in humans. Proc Natl Acad Sci 2001, 98:2017-2022.
34. Paxinos G., Franklin K.B.J. The mouse brain in stereotaxic coordinates 2001, Academic Press, San Diego, CA.
35. Pfaffl M.W., Horgan G.W., Dempfle L. Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucl Acids Res 2002, 30:e36.
36. Prado M.A.M., Reis R.A.M., Prado V.F., De Mello M.C., Gomez M.V., De Mello F.G. Regulation of acetylcholine synthesis and storage. Neurochem Int 2002, 41:291-299.
37. Prado V.F., Martins-Silva C., de Castro B.M., Lima R.F., Barros D.M., Amaral E., Ramsey A.J., Sotnikova T.D., Ramirez M.R., Kim H.G., Rossato J.I., Koenen J., Quan H., Cota V.R., Moraes M.F.D., Gomez M.V., Guatimosim C., Wetsel W.C., Kushmerick C., Pereira G.S., Gainetdinov R.R., Izquierdo I., Caron M.G., Prado M.A.M. Mice deficient for the vesicular acetylcholine transporter are myasthenic and have deficits in object and social recognition. Neuron 2006, 51:601-612.
38. Rizzoli S.O., Betz W.J. Synaptic vesicle pools. Nat Rev Neurosci 2005, 6:57-69.
39. Sarter M., Parikh V. Choline transporters, cholinergic transmission and cognition. Nat Rev Neurosci 2005, 6:48-56.
40. Schütz B., Weihe E., Eiden L.E. Independent patterns of transcription for the products of the rat cholinergic gene locus. Neuroscience 2001, 104:633-642.
41. Sia Y., Bourne J.A. The rat temporal association cortical area 2 (Te2) comprises two subdivisions that are visually responsive and develop independently. Neuroscience 2008, 156:118-128.
42. Song H., Ming G., Fon E., Bellocchio E., Edwards R.H., Poo M.M. Expression of a putative vesicular acetylcholine transporter facilitates quantal transmitter packaging. Neuron 1997, 18:815-826.
43. Takei K., Mundigl O., Daniell L., De Camilli P. The synaptic vesicle cycle: a single vesicle budding step involving clathrin and dynamin. J Cell Biol 1996, 133:1237-1250.
44. Tallini Y.N., Shui B., Greene K.S., Deng K.Y., Doran R., Fisher P.J., Zipfel W., Kotlikoff M.I. BAC transgenic mice express enhanced green fluorescent protein in central and peripheral cholinergic neurons. Physiol Genomics 2006, 27:391-397.
45. Tucek S., Zelena J., Ge I., Vyskocil F. Choline acetyltransferase in transected nerves, denervated muscles and Schwann cells of the frog: correlation of biochemical, electron microscopical and electrophysiological observations. Neuroscience 1978, 3:709-724.
46. van Keuren M.L., Gavrilina G.B., Filipiak W.E., Zeidler M.G., Saunders T.L. Generating transgenic mice from bacterial artificial chromosomes: transgenesis efficiency, integration and expression outcomes. Transgenic Res 2009, 18:769-785.
47. Volpicelli-Daley L.A., Hrabovska A., Duysen E.G., Ferguson S.M., Blakely R.D., Lockridge O., Levey A.I. Altered striatal function and muscarinic cholinergic receptors in acetylcholinesterase knockout mice. Mol Pharmacol 2003, 64:1309-1316.
48. Wenk G., Sweeney J., Hughey D. Cholinergic function and memory: extensive inhibition of choline acetyltransferase fails to impair radial maze performance in rats. Pharmacol Biochem Behav 1986, 25:521-526.